LabHealth
Two blood proteins linked to future disability in adults 85+
B2M and cystatin C were associated with higher disability risk in 230 disability-free Japanese adults.
Written by AI1 source2 min
Loading…
Diagnostics, prosthetics, vaccines, genomics: the medicine that adds years to a life.
Medicine that wins years of life: AI-assisted screening examining millions of patients, next-generation vaccines, genomics moving from sequencing to treatment, prosthetics and implants restoring lost abilities. The section follows completed clinical trials, market authorisations, hospital roll-outs — the moment a technology stops being a paper and becomes care.
The numbers rule: cohorts, detection rates, avoided mortality, costs. We gladly cover the health systems deploying at scale — India, Brazil, Southeast Asia — because frugal technologies often prove themselves there before arriving anywhere else. Every article rests on the trial, authorisation or study behind it, and cites them.
B2M and cystatin C were associated with higher disability risk in 230 disability-free Japanese adults.
The study compared immunotherapy alone with a chemotherapy-immunotherapy combination before surgery.
The Danish study involved 60 adults and used PET/MR imaging to examine dopamine, glucose metabolism and brain communication.
It targets podocytes in the kidney and hepatocytes in the liver, two cell types tied to age-related disease.
The open-source project brings fNIRS and DOT analysis into one Python workflow.
NIH researchers linked the effect to heat, not necessarily the immune response behind a fever.
The analysis covered nine randomized trials involving 1,258 adults with recurrent depression in remission.
An iron supplement raised survival from 50% to 100% in mice with Citrobacter rodentium.
The ACCESS trial studied 268 adults whose donors were mismatched at six of eight key HLA markers.
University of Missouri researchers used Torin 2 to enhance autophagy, the cell’s cleanup and recycling process.
Drexel and UC Davis researchers tested WeCareAdvisor with family caregivers over three months.
Salk researchers linked the attack to TAM proteins, especially Axl and Mer.
The SF-10 checks five social-risk domains in a brief screening tool for older adults.
Celltrion received Japanese approval in April and launched the IV version about four months later.
The hospital says the implant is the world's first personalized bone metamaterial prosthesis.
A UNC-led trial adapted Mediterranean-style eating to foods common in the Southeast.
The remote trial followed 825 adults across 13 countries, with outcomes measured after 12 weeks.
The estimate comes from Sweden’s Stockholm–Gotland program, followed for up to 14 years.